A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.

CNS spectrums

Volumn 18, Issue 3, 2013, Pages 163-170

  Demyttenaere, Koen ^a   Corruble, Emanuelle ^b   Hale, Anthony ^b   Quera Salva, Maria Antonia ^b   Picarel Blanchot, Françoise ^b   Kasper, Siegfried ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; AGOMELATINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; SERTRALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ACETAMIDES; ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SERTRALINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881240340     PISSN: 10928529     EISSN: None     Source Type: None    
DOI: 10.1017/S1092852913000060     Document Type: Article

References (0)